cd22735

forkhead associated (FHA) domain found in aprataxin and similar proteins

CDD entry
Member databaseCDD
CDD typedomain
Short nameFHA_APTX
SetFHA

Description

Aprataxin (EC 3.6.1.71/EC 3.6.1.72), also called forkhead-associated domain histidine triad-like protein (FHA-HIT), is a DNA-binding protein involved in single-strand DNA break repair, double-strand DNA break repair, and base excision repair. It catalyzes the release of adenylate groups covalently linked to 5'-phosphate termini, resulting in the production of 5'-phosphate termini that can be efficiently rejoined. It can also hydrolyze adenosine 5'-monophosphoramidate (AMP-NH(2)) and diadenosine tetraphosphate (AppppA), but with lower catalytic activity. Likewise, it catalyzes the release of 3'-linked guanosine (DNAppG) and inosine (DNAppI) from DNA but has higher specific activity with 5'-linked adenosine (AppDNA). Mutations in the gene APTX have been associated with ataxia-ocular apraxia. Aprataxin contains an FHA domain at its N-terminus. The FHA domain is a small phosphopeptide recognition module.
[10, 13, 16, 1, 7, 14, 4, 5, 11, 3, 17, 9, 6, 12, 2, 8, 15]

References

1.The gene mutated in ataxia-ocular apraxia 1 encodes the new HIT/Zn-finger protein aprataxin. Moreira MC, Barbot C, Tachi N, Kozuka N, Uchida E, Gibson T, Mendonca P, Costa M, Barros J, Yanagisawa T, Watanabe M, Ikeda Y, Aoki M, Nagata T, Coutinho P, Sequeiros J, Koenig M. Nat Genet 29, 189-93, (2001). PMID: 11586300

2.Cerebellar ataxia with oculomotor apraxia type 1: clinical and genetic studies. Le Ber I, Moreira MC, Rivaud-Pechoux S, Chamayou C, Ochsner F, Kuntzer T, Tardieu M, Said G, Habert MO, Demarquay G, Tannier C, Beis JM, Brice A, Koenig M, Durr A. Brain 126, 2761-72, (2003). PMID: 14506070

3.The neurodegenerative disease protein aprataxin resolves abortive DNA ligation intermediates. Ahel I, Rass U, El-Khamisy SF, Katyal S, Clements PM, McKinnon PJ, Caldecott KW, West SC. Nature 443, 713-6, (2006). View articlePMID: 16964241

4.Aprataxin, a novel protein that protects against genotoxic stress. Gueven N, Becherel OJ, Kijas AW, Chen P, Howe O, Rudolph JH, Gatti R, Date H, Onodera O, Taucher-Scholz G, Lavin MF. Hum. Mol. Genet. 13, 1081-93, (2004). View articlePMID: 15044383

5.Nucleolar localization of aprataxin is dependent on interaction with nucleolin and on active ribosomal DNA transcription. Becherel OJ, Gueven N, Birrell GW, Schreiber V, Suraweera A, Jakob B, Taucher-Scholz G, Lavin MF. Hum Mol Genet 15, 2239-49, (2006). PMID: 16777843

6.Early-onset ataxia with ocular motor apraxia and hypoalbuminemia: the aprataxin gene mutations. Shimazaki H, Takiyama Y, Sakoe K, Ikeguchi K, Niijima K, Kaneko J, Namekawa M, Ogawa T, Date H, Tsuji S, Nakano I, Nishizawa M. Neurology 59, 590-5, (2002). PMID: 12196655

7.Aprataxin, the causative protein for EAOH is a nuclear protein with a potential role as a DNA repair protein. Sano Y, Date H, Igarashi S, Onodera O, Oyake M, Takahashi T, Hayashi S, Morimatsu M, Takahashi H, Makifuchi T, Fukuhara N, Tsuji S. Ann Neurol 55, 241-9, (2004). PMID: 14755728

8.Very late onset in ataxia oculomotor apraxia type I. Criscuolo C, Mancini P, Menchise V, Sacca F, De Michele G, Banfi S, Filla A. Ann Neurol 57, 777, (2005). PMID: 15852392

9.Aprataxin resolves adenylated RNA-DNA junctions to maintain genome integrity. Tumbale P, Williams JS, Schellenberg MJ, Kunkel TA, Williams RS. Nature 506, 111-5, (2014). View articlePMID: 24362567

10.CK2 phosphorylation-dependent interaction between aprataxin and MDC1 in the DNA damage response. Becherel OJ, Jakob B, Cherry AL, Gueven N, Fusser M, Kijas AW, Peng C, Katyal S, McKinnon PJ, Chen J, Epe B, Smerdon SJ, Taucher-Scholz G, Lavin MF. Nucleic Acids Res. 38, 1489-503, (2010). View articlePMID: 20008512

11.Aprataxin forms a discrete branch in the HIT (histidine triad) superfamily of proteins with both DNA/RNA binding and nucleotide hydrolase activities. Kijas AW, Harris JL, Harris JM, Lavin MF. J. Biol. Chem. 281, 13939-48, (2006). View articlePMID: 16547001

12.Phenotypic variability of aprataxin gene mutations. Tranchant C, Fleury M, Moreira MC, Koenig M, Warter JM. Neurology 60, 868-70, (2003). PMID: 12629250

13.Novel splice variants increase molecular diversity of aprataxin, the gene responsible for early-onset ataxia with ocular motor apraxia and hypoalbuminemia. Hirano M, Nishiwaki T, Kariya S, Furiya Y, Kawahara M, Ueno S. Neurosci Lett 366, 120-5, (2004). PMID: 15276230

14.The ataxia-oculomotor apraxia 1 gene product has a role distinct from ATM and interacts with the DNA strand break repair proteins XRCC1 and XRCC4. Clements PM, Breslin C, Deeks ED, Byrd PJ, Ju L, Bieganowski P, Brenner C, Moreira MC, Taylor AM, Caldecott KW. DNA Repair (Amst.) 3, 1493-502, (2004). View articlePMID: 15380105

15.Coenzyme Q deficiency and cerebellar ataxia associated with an aprataxin mutation. Quinzii CM, Kattah AG, Naini A, Akman HO, Mootha VK, DiMauro S, Hirano M. Neurology 64, 539-41, (2005). PMID: 15699391

16.Early-onset ataxia with ocular motor apraxia and hypoalbuminemia is caused by mutations in a new HIT superfamily gene. Date H, Onodera O, Tanaka H, Iwabuchi K, Uekawa K, Igarashi S, Koike R, Hiroi T, Yuasa T, Awaya Y, Sakai T, Takahashi T, Nagatomo H, Sekijima Y, Kawachi I, Takiyama Y, Nishizawa M, Fukuhara N, Saito K, Sugano S, Tsuji S. Nat. Genet. 29, 184-8, (2001). View articlePMID: 11586299

17.Actions of aprataxin in multiple DNA repair pathways. Rass U, Ahel I, West SC. J. Biol. Chem. 282, 9469-74, (2007). View articlePMID: 17276982

Integrated to
External Links
This website requires cookies, and the limited processing of your personal data in order to function. By using the site you are agreeing to this as outlined in our Privacy Notice and Terms of Use.